In particular, HFn has been noted to bind human cells by interacting with transferrin receptor 1 (TfR1), which is highly expressed on cancer cells and is commonly used as a targeting marker for tumor diagnosis and therapy [135,136]. This evidence concerns the gene TFRC and neoplasm.